Health Trials

ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)

ConditionCommunity Acquired Pneumonia (CAP)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSocieta Italiana di Pneumologia

About this trial

This multicentric, prospective study aims at:

evaluating the prevalence, etiology, characteristics, and 1one-year outcomes of immunocompromised patients hospitalized for Community-Acquired Pneumonia (CAP); conducting biochemical, microbiological and genetic analysis on collected samples.

Eligibility criteria

Qualifiers

AIDS,

Aplastic anemia;

Asplenia;

Hematologic malignancy (e.g., lymphoma/acute or chronic myeloid leukemia/multiple myeloma);

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano Via Francesco Sforza 35 20122 Milan Italy20122, MilanMilano, Italy

Sponsors and collaborators

Societa Italiana di Pneumologia

Lead sponsor

Source ClinicalTrials.gov